Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
About the LCSB The University of Luxembourg is an international research university with a distinctly multilingual and interdisciplinary character. The Luxembourg Centre for Systems Biomedicine
-
research projects. Training and research environment The Facility supports the research groups of LIH and local partners by providing high quality animal experimentation services. State-of-the-art
-
. Collaborate with people with diabetes, diabetologists, software engineers, and clinical psychologists to develop and validate prototype tools. Contribute to qualitative and mixed-methods research to ensure user
-
'catch-up' meetings and monthly work-in-progress meetings Present original research at workshops and conferences Assist with the organization of a conference and an exhibition Attend and participate at two
-
30 months contract | Belval-Luxembourg Are you passionate about research? So are we! Come and join us The Luxembourg Institute of Science and Technology (LIST) is a mission-driven Research and
-
A 10-month (potentially renewable) laboratory assistant position (Ingénieur d’études) is available in the Genetics of Rare Ophthalmological, Auditory, and Mitochondrial Diseases laboratory
-
position with visibility and impact. Key Responsibilities • Lead and execute experimental research in spintronics: fabrication, magnetic/electrical characterization, data analysis, and simulation. • Develop
-
-supervision by a doctor and a statistical/machine-learning researcher is planned (iBV / Inria) 1- Context and Objective: Monitoring tumor response using clinical imaging, such as CT or FDG-PET, has become a
-
/CT imaging Description of the topic As this is an interdisciplinary "AI and medicine" project, co-supervision by a doctor and a statistical/machine-learning researcher is planned (iBV / Inria) 1
-
to differentiate into effector-like cells to reduce tumor burden. Recent findings highlight a central role for CD4 help in both supporting CD8 T cell cytotoxicity and success of PD-1 targeted therapy. However